恶性肿瘤患者疼痛相关性压疮的临床效果分析

Clinical Analysis of Pain-related Pressure Ulcer in Patients with Malignant Tumor

目的对恶性肿瘤患者疼痛相关性压疮实施规范化管理的临床效果进行探析。方法回顾性研究2016年1月—2017年12月在该院肿瘤内科住院治疗的217例恶性肿瘤疼痛患者的临床资料,将2016年度实施常规压疮管理的102例患者纳入对照组,将2017年度实施规范化管理的115例患者纳入观察组,对比分析两组疼痛相关性压疮发生率,并评测入院7 d时的压疮风险量表评分(Braden)。结果观察组疼痛相关性压疮发生率为1.74%,显著低于对照组的6.86%,差异有统计学意义(χ~2=4.398,P<0.05);通过评测,观察组患者入院7 d时Braden中的身体活动度、体位改变评分均高于对照组,差异有统计学意义(t=1.112、8.287,P<0.05),但摩擦力与剪切力评分差异无统计学意义(t=0.283,P>0.05);观察组患者压疮愈合时间短于对照组,差异有统计学意义(t=10.297,P<0.05)。结论在恶性肿瘤疼痛患者治疗中开展压疮规范化管理,可有效降低疼痛相关性压疮发生风险,降低发生率,并有助于压疮患者更好治愈,临床意义重大。

Objective To analyze the clinical effect of standardized management of pain-related pressure ulcers in patients with malignant tumors. Methods The clinical data of 217 patients with malignant tumor pain who were hospitalized in our hospital from January 2016 to December 2017 were retrospectively reviewed. 102 patients who underwent conventional pressure ulcer management in 2016 were included in the control group. A total of 115 patients who underwent standardized management were included in the observation group. The incidence of pain-related pressure ulcers was compared and analyzed. The pressure ulcer scale score(Braden) at 7 days after admission was evaluated. Results The incidence of pain-related pressure ulcers in the observation group was 1.74%, which was significantly lower than 6.86% in the control group,the difference was statistically significant(χ2=4.398,P <0.05). The body activity and position changes in Braden were observed in the observation group on the 7 th day after admission, higher than the control group,the difference was statistically significant(t=1.112, 8.287, P<0.05), but there was no significant difference between the friction and shear scores,the difference was statistically significant(t=0.283,P>0.05). The observation group had shorter healing time of pressure ulcers than the control group,the difference was statistically significant(t=10.297,P<0.05). Conclusion The standardized management of pressure ulcers in the treatment of patients with malignant tumor pain can effectively reduce the risk of pain-related pressure ulcers, reduce the incidence, and help patients with pressure ulcers to better cure, which is of great clinical significance.